Shingles

NeoVac is leveraging its LNP platform to develop a safer and more affordable vaccine for Shingles

Shingles is a painful viral infection that can recur and currently has no cost-effective vaccine.

1. Shingles (herpes zoster): A painful reappearance of an old viral infection, typically occurring in > 60-year-old or immunocompromised individuals

2. Existing vaccines have limitations: Zostavax is discontinued due to poor efficacy, while Shingrix is highly effective but costly (~$170–190 per dose, two doses required)

Plague